🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Janis Pruett

Sumitomo Dainippon Pharma (United States)

ORCID: 0000-0003-1434-0244

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Assessing racial differences in time to subsequent treatment following androgen deprivation therapy among Veterans with prostate cancer”.

Assessing racial differences in time to subsequent treatment following androgen deprivation therapy among Veterans with prostate cancer

Research Square(2024)10.21203/rs.3.rs-5001707/v1

N/A

0.104DataRank · unranked

1 citations

Jessica L. Janes, Joshua Parrish, Amanda M. De Hoedt, Janis Pruett, Mark Fallick +5 more

Assessing racial differences in time to subsequent treatment following androgen deprivation therapy among Veterans with prostate cancer

Prostate Cancer and Prostatic Diseases(2025)10.1038/s41391-025-00995-4

N/A

0.104DataRank · unranked

1 citations

Jessica L. Janes, Joshua Parrish, Amanda M. De Hoedt, Janis Pruett, Mark Fallick +5 more

Assessing racial differences in time to treatment escalation following androgen-deprivation therapy among veterans with prostate cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5078

N/A

0DataRank · unranked

0 citations

Jessica L. Janes, Joshua Parrish, Amanda Marie De Hoedt, Janis Pruett, Mark Fallick +5 more